Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Equillium initiates phase Ib study of itolizumab in lupus nephritis

Oct. 2, 2019

Dual CB1R/iNOS antagonist MRI-1867 ameliorates obesity-induced CKD in vivo

Sep. 27, 2019

Senolytics work as advertised

Sep. 25, 2019

Finding a balance in treating diabetic kidney damage

Sep. 23, 2019

Novel glomerulus-on-a-chip for renal disease modeling and drug testing

Sep. 23, 2019

A1M reports initial phase Ia data on ROSgard

Sep. 20, 2019

Xortx reports promising phase II data with TMX-049 in type 2 diabetic nephropathy

Sep. 20, 2019

Design of novel zebrafish models of cystinosis

Sep. 16, 2019

Phase III AMPLIFY study of phosphate absorption inhibitor tenapanor meets primary endpoint

Sep. 4, 2019

Eli Lilly and Company describes PDE1 inhibitors

Sep. 3, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...